These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 21177869)

  • 1. mTOR-dependent regulation of PHLPP expression controls the rapamycin sensitivity in cancer cells.
    Liu J; Stevens PD; Gao T
    J Biol Chem; 2011 Feb; 286(8):6510-20. PubMed ID: 21177869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of PHLPP expression contributes to hypoxia-induced resistance to chemotherapy in colon cancer cells.
    Wen YA; Stevens PD; Gasser ML; Andrei R; Gao T
    Mol Cell Biol; 2013 Nov; 33(22):4594-605. PubMed ID: 24061475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth-factor dependent expression of the translationally controlled tumour protein TCTP is regulated through the PI3-K/Akt/mTORC1 signalling pathway.
    Bommer UA; Iadevaia V; Chen J; Knoch B; Engel M; Proud CG
    Cell Signal; 2015 Aug; 27(8):1557-68. PubMed ID: 25936523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal tumours in a Tsc2(+/-) mouse model do not show feedback inhibition of Akt and are effectively prevented by rapamycin.
    Yang J; Kalogerou M; Samsel PA; Zhang Y; Griffiths DF; Gallacher J; Sampson JR; Shen MH
    Oncogene; 2015 Feb; 34(7):922-31. PubMed ID: 24632604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53/TAp63 and AKT regulate mammalian target of rapamycin complex 1 (mTORC1) signaling through two independent parallel pathways in the presence of DNA damage.
    Cam M; Bid HK; Xiao L; Zambetti GP; Houghton PJ; Cam H
    J Biol Chem; 2014 Feb; 289(7):4083-94. PubMed ID: 24366874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual inhibition of phosphatidylinositol 3-kinase/Akt and mammalian target of rapamycin signaling in human nonsmall cell lung cancer cells by a dietary flavonoid fisetin.
    Khan N; Afaq F; Khusro FH; Mustafa Adhami V; Suh Y; Mukhtar H
    Int J Cancer; 2012 Apr; 130(7):1695-705. PubMed ID: 21618507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different patterns of Akt and ERK feedback activation in response to rapamycin, active-site mTOR inhibitors and metformin in pancreatic cancer cells.
    Soares HP; Ni Y; Kisfalvi K; Sinnett-Smith J; Rozengurt E
    PLoS One; 2013; 8(2):e57289. PubMed ID: 23437362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapamycin attenuates BAFF-extended proliferation and survival via disruption of mTORC1/2 signaling in normal and neoplastic B-lymphoid cells.
    Zeng Q; Qin S; Zhang H; Liu B; Qin J; Wang X; Zhang R; Liu C; Dong X; Zhang S; Huang S; Chen L
    J Cell Physiol; 2018 Jan; 233(1):516-529. PubMed ID: 28300280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-threonine regulates G1/S phase transition of mouse embryonic stem cells via PI3K/Akt, MAPKs, and mTORC pathways.
    Ryu JM; Han HJ
    J Biol Chem; 2011 Jul; 286(27):23667-78. PubMed ID: 21550972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1/4E-BP1 axis.
    Mi W; Ye Q; Liu S; She QB
    Oncotarget; 2015 Jun; 6(16):13962-77. PubMed ID: 25961827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PHLPP-mediated dephosphorylation of S6K1 inhibits protein translation and cell growth.
    Liu J; Stevens PD; Li X; Schmidt MD; Gao T
    Mol Cell Biol; 2011 Dec; 31(24):4917-27. PubMed ID: 21986499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of rapamycin sensitivity in breast cancer cells.
    Noh WC; Mondesire WH; Peng J; Jian W; Zhang H; Dong J; Mills GB; Hung MC; Meric-Bernstam F
    Clin Cancer Res; 2004 Feb; 10(3):1013-23. PubMed ID: 14871980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapamycin inhibits cytoskeleton reorganization and cell motility by suppressing RhoA expression and activity.
    Liu L; Luo Y; Chen L; Shen T; Xu B; Chen W; Zhou H; Han X; Huang S
    J Biol Chem; 2010 Dec; 285(49):38362-73. PubMed ID: 20937815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of PHLPP induced by endoplasmic reticulum stress promotes eIF2α phosphorylation and chemoresistance in colon cancer.
    Guo B; Xiong X; Hasani S; Wen YA; Li AT; Martinez R; Skaggs AT; Gao T
    Cell Death Dis; 2021 Oct; 12(11):960. PubMed ID: 34663797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGFβ- and bleomycin-induced extracellular matrix synthesis is mediated through Akt and mammalian target of rapamycin (mTOR).
    Goc A; Choudhary M; Byzova TV; Somanath PR
    J Cell Physiol; 2011 Nov; 226(11):3004-13. PubMed ID: 21302298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The deubiquitination enzyme USP46 functions as a tumor suppressor by controlling PHLPP-dependent attenuation of Akt signaling in colon cancer.
    Li X; Stevens PD; Yang H; Gulhati P; Wang W; Evers BM; Gao T
    Oncogene; 2013 Jan; 32(4):471-8. PubMed ID: 22391563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers.
    Zhou X; Tan M; Stone Hawthorne V; Klos KS; Lan KH; Yang Y; Yang W; Smith TL; Shi D; Yu D
    Clin Cancer Res; 2004 Oct; 10(20):6779-88. PubMed ID: 15501954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mammalian target of rapamycin regulates cholesterol biosynthetic gene expression and exhibits a rapamycin-resistant transcriptional profile.
    Wang BT; Ducker GS; Barczak AJ; Barbeau R; Erle DJ; Shokat KM
    Proc Natl Acad Sci U S A; 2011 Sep; 108(37):15201-6. PubMed ID: 21876130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphomimetic substitution of heterogeneous nuclear ribonucleoprotein A1 at serine 199 abolishes AKT-dependent internal ribosome entry site-transacting factor (ITAF) function via effects on strand annealing and results in mammalian target of rapamycin complex 1 (mTORC1) inhibitor sensitivity.
    Martin J; Masri J; Cloninger C; Holmes B; Artinian N; Funk A; Ruegg T; Anderson L; Bashir T; Bernath A; Lichtenstein A; Gera J
    J Biol Chem; 2011 May; 286(18):16402-13. PubMed ID: 21454539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin promotes vascular smooth muscle cell differentiation through insulin receptor substrate-1/phosphatidylinositol 3-kinase/Akt2 feedback signaling.
    Martin KA; Merenick BL; Ding M; Fetalvero KM; Rzucidlo EM; Kozul CD; Brown DJ; Chiu HY; Shyu M; Drapeau BL; Wagner RJ; Powell RJ
    J Biol Chem; 2007 Dec; 282(49):36112-20. PubMed ID: 17908691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.